-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.00421.74% Upside
Dermata Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Dermata Therapeutics, Inc.?
Dermata Therapeutics, Inc. has been rated by research analysts at Maxim Group in the past 90 days.